Novel high throughput screen identifies an HIV 1 reverse transcriptase inhibitor with a unique mechanism of action
Biochemical Journal, Vol. 462, No. 3, Eylül 2014, s. 425-432, ISSN: 0264-6021
SHEEN CHİH WEİ, ALPTÜRK ONUR, SLUİSCREMER NİCOLAS
|
In silico methods predict new blood-brain barrier permeable structure for the inhibition of kynurenine 3-monooxygenase
JOURNAL OF MOLECULAR GRAPHICS MODELLING, Vol. 100, No. null, Kasım 2020, ISSN: 1093-3263
ÖZKILIÇ YILMAZ,TÜZÜN NURCAN
|
Physics-driven discovery of novel small therapeutic compounds for use as a bcl-2 inhibitor
Patent No: 17929003, Patent Sınıfı: A1, 2023
MÜGE DİDEM ORHAN ,SERDAR DURDAGİ,BERNA DOGAN,SEYMA CALİS,GURBET CACAN,TİMUCİN AVSAR
|
PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR
Patent No: 20230088086, Patent Sınıfı: A1, 2023
MÜGE DİDEM ORHA,BERNA DOGAN,SEYMA CALİS,GURBET CACAN,TİMUCİN AVSAR,SERDAR DURDAGİ
|
PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR
Patent No: 20230090414, 2023
BERNA DOGAN,SERDAR DURDAGİ,GURBET CACAN,SEYMA CALİS,TİMUCİN AVSAR,MUGE DİDEM ORHAN
|
PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR
Patent No: 20230109522, Patent Sınıfı: A1, 2023
BERNA DOĞAN ,TİMUÇİN AVŞAR ,ŞEYMA ÇALIŞ ,GURBET ÇAÇAN ,SERDAR DURDAĞI ,MÜGE DİDEM ORHAN
|
Drg-mdm2-3 for use as a novel mouse double minute 2 (mdm2) inhibitor
Patent No: US-20230067644-A1, Patent Sınıfı: A1, 2023
SERDAR DURDAGİ, MUGE ORHAN, TİMUCİN AVSAR, MAİDE PAKSOY, GULSAH AYDİN, MİNE YURTSEVER
|
Drg-mdm2-5 for use as a novel mouse double minute 2 (mdm2) inhibitor
Patent No: US-20230063449-A1, Patent Sınıfı: A1, 2023
SERDAR DURDAGİ, TİMUCİN AVSAR, MİNE YURTSEVER, GULSAH AYDİN, MAİDE NUR PAKSOY, MUGE DİDEM ORHAN
|
DRG-MDM2-4 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR
Patent No: US-20230071340-A1, Patent Sınıfı: A1, 2023
TİMUCİN AVSAR, SERDAR DURDAGİ, MUGE DİDEM ORHAN, MAİDE NUR PAKSOY, GULSAH AYDİN, MİNE YURTSEVER
|
DRG-MDM2-1 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR
Patent No: US-20230073261-A1, Patent Sınıfı: A1, 2023
SERDAR DURDAGİ, TİMUCİN AVSAR, MUGE DİDEM ORHAN, MAİDE NUR PAKSOY, GULSAH AYDİN, MİNE YURTSEVER
|
A NOVEL SELECTIVE MAO-B INHIBITOR DRG-MAOB-2 FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES
Patent No: US-20230088611-A1, Patent Sınıfı: A1, 2023
SERDAR DURDAĞI, MİNE YURTSEVER,BUSECAN AKSOYDAN, MURAT SENTURK
|
A NOVEL MAO-B INHIBITOR DRG-MAOB-1 FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES
Patent No: US-20230093302-A1, Patent Sınıfı: A1, 2023
SERDAR DURDAGİ,MİNE YURTSEVER,BUSECAN SERHAT AKSOYDAN, MURAT SENTURK
|
DRG-MDM2-6 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR
Patent No: US-20230098888-A1, Patent Sınıfı: A1, 2023
MİNE YURTSEVER, MUGE DİDEM ORHAN, MAİDE NUR PAKSOY, GULSAH AYDİN, TİMUCİN AVSAR, SERDAR DURDAGİ
|
To elucidate the interaction mechanism of CNS selective carbamate-type cholinesterase (CHE) inhibitor rivastigmine with dsDNA by multi-spectroscopic, electrochemical, and viscosimetric methods
Lisansüstü Eğitim Enstitüsü, İstanbul Teknik Üniversitesi, 2022
NEDA ALIZADEH
|
Investigation of the effect of valproic acid, an hdac inhibitor, on the relationship between oxidative stress and autophagy in human eosinophil
Lisansüstü Eğitim Enstitüsü, İstanbul Teknik Üniversitesi, 2022
GÖKSU ÜZEL TURAN
|